As a consequence of a review of its global R&D structures, the company will close this subsidiary located on Kobe’s Port Island which was acquired from Suntory in 2005. The 150 employees will be distributed to other Daiichi-Sankyo’s subsidiaries.
Nikkei Journal news February 10, 2017
Daiichi-Sankyo closes subsidiary Asbio Pharma